An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone who started taking the new Wegovy pill (an oral form of a weight-loss drug) wrote about their experience: they could afford it at the announced $150 tier, are taking 4 mg, and while the drug reduces appetite as intended, a big downside has been constipation. They tried the usual advice—more fiber, more protein—but still feel the drug makes them so constipated that it cuts appetite, which they didn’t like even though they appreciated eating less. Wegovy is a brand name for semaglutide, a medicine that acts like a hormone your gut makes after you eat. In plain terms, semaglutide tricks your body into feeling fuller and slows how quickly your stomach empties. That’s why people eat less and can lose weight. There are injectable versions used for diabetes and weight loss, and now there’s a pill form meant to do the same thing more conveniently. The snippet is a single-person account, not a study. It’s honest real-world experience from one user on a specific dose who noticed a lot of constipation. Clinical trials and medical literature do list gastrointestinal side effects for semaglutide—things like nausea, diarrhea, and constipation are common—but individual experiences vary a lot. The post suggests constipation was severe enough to suppress appetite further, but we can’t generalize how often that happens or how intense it will be for others from this anecdote alone. Why this matters: constipation is more than an annoyance. It can make people uncomfortable, affect mood, and sometimes lead to complications if severe or untreated. For someone taking a weight-loss drug, reduced appetite is the goal, but if that effect comes mainly from being uncomfortably constipated, that’s a poor trade-off. People thinking about trying Wegovy or other semaglutide drugs should know that bowel changes are common and worth planning for—hydration, fiber, exercise, and talking to a provider about safe laxatives or dose adjustments may help. Caveats and risks: this is one person’s story, not a controlled comparison. Semaglutide is FDA-approved for certain doses and uses, but the pill format and price tiers may affect who can access it. Side effects vary—some people get nausea or diarrhea instead of constipation. Don’t self-medicate without checking with a clinician, especially if you have digestive disease, are pregnant, or take other medications. If constipation is severe, persistent, or comes with pain or blood, seek medical care. Bottom line: semaglutide pills can cut appetite and help with weight loss, but some people experience significant constipation, and that trade-off is worth discussing with a doctor before starting.
Source: r/Semaglutide